Skip to content

Study to Demonstrate the Safety and Performance of the VASCADE 5F Vascular Closure System (VCS)

Femoral Artery closure using the Cardiva VASCADE 5F Vascular Closure System (VCS) to reduce time to hemostasis and reduce time to ambulation and hospital discharge in patients who have undergone diagnostic or interventional endovascular catheterization procedures utilizing 5 French procedural sheaths

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611001247965
Enrollment
30
Registered
2011-12-06
Start date
2011-12-07
Completion date
2012-02-29
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The Cardiva VASCADE VCS consists of a sterile disposable catheter containing a deployable extravascular collagen path and a clip. The VASCADE VCS is intended to seal or close the femoral arterial access site while reducing time to hemostasis (stop the bleeding process), time to ambulation (when a person can walk), and time to hospital discharge in subjects who have undergone diagnostic or interventional endovascular procedures.

Interventions

The Cardiva VASCADE VCS consists of a sterile disposable catheter containing a deployable extravascular collagen patch and a clip. The VASCADE VCS is intended to seal a femoral arterial access site at the end of any procedure that uses a 5 French introducer sheath to access the femoral artery. This is a one time use device. The procedure of deploying the collagen patch takes less than 3-5 minutes.

Sponsors

Cardiva Medical, Inc.
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Clinically indicated for an elective, non-emergent diagnostic or interventional endovascular procedure via the common femoral artery using a 5 Fr introducer sheath

Exclusion criteria

Key Pre-Operative Exclusion Criteria 1. Active systemic or a cutaneous infection 2. Pre-existing immunodeficiency disorder and/or chronic use of systemic steroids 3. Ipsilateral femoral arteriotomy within the previous 30 days 4. Planned endovascular procedure within the next 30 days 5. Unilateral or bilateral lower extremity amputation(s) 6. Extreme morbid obesity [Body Max Index (BMI) greater than 45 kg/m2] or underweight (BMI less than 22 kg/m2) 7. Difficult insertion of procedural sheath or needle stick problems at the onset of the procedure (e.g., multiple stick attempts, "back“wall stick”, etc.) 8. Fluoroscopically visible calcium, atherosclerotic disease, or stent within 1 cm of the puncture site

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 4, 2026